Translational Oncology
Overview
Translational Oncology is a peer-reviewed journal that focuses on bridging the gap between basic science and clinical research in the field of oncology. It publishes cutting-edge studies that aim to translate laboratory discoveries into practical applications for cancer prevention, diagnosis, and treatment. The journal serves as a platform for researchers, clinicians, and policymakers to share their findings and insights, ultimately advancing the understanding and management of cancer.
Details
Details
Abbr.
Transl Oncol
Start
2007
End
Continuing
e-ISSN
1936-5233
Country
United States
Language
English
Specialty
Oncology
Metrics
Metrics
h-index / Ranks: 4950
72
SJR / Ranks: 2603
1263
CiteScore / Ranks: 2750
7.20
JIF / Ranks: 1573
5.0
Recent Articles
11.
Qin Z, Ye F, Wang J, Jiang J, Zhang X, Li H, et al.
Transl Oncol
. 2025 Mar;
54:102334.
PMID: 40056529
Background: Cisplatin resistance significantly impedes the treatment of gastric cancer (GC). This work examined the possible therapeutic target status and function of BUB1B in controlling cisplatin resistance. Methods: Following the...
12.
Ma Z, Hua J, Wei M, Han L, Dong M, Xie W, et al.
Transl Oncol
. 2025 Mar;
54:102346.
PMID: 40056528
Pancreatic cancer is an aggressive malignancy characterized by rapid progression, unfavorable outcomes, and a low early detection rate. Elucidating the mechanisms underlying the onset and progression of pancreatic tumors is...
13.
Frederick M, Fyle E, Clouvel A, Abdesselam D, Hassan S
Transl Oncol
. 2025 Mar;
54:102337.
PMID: 40054125
Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer. The only targeted therapeutic approach that has emerged for early TNBC patients with BRCA-mutations (BRCA) are PARP inhibitors...
14.
Albakova Z
Transl Oncol
. 2025 Mar;
54:102342.
PMID: 40054124
Inflammasomes are cytoplasmic macromolecular complexes playing an important role in sensing exogenous and endogenous stimuli. Inflammasome activation leads to IL-1β and IL-18 secretion and pyroptosis. The concept of non-self recognition...
15.
Huang M, Zhu X, Xu W, Zhu J, Xun X, Su B, et al.
Transl Oncol
. 2025 Mar;
54:102345.
PMID: 40054123
Non-small cell lung cancer (NSCLC) remains a leading cause of cancer-related mortality worldwide. ALK gene rearrangement has been identified in 3 % to 5 % of the patients with NSCLC....
16.
Wu Y, Fan L, Shao H, Li J, Yin W, Yin J, et al.
Transl Oncol
. 2025 Mar;
54:102335.
PMID: 40048985
Background: Accurate early diagnosis of ovarian cancer is crucial. The objective of this research is to create a comprehensive model that merges clinical variables, O-RADS, and deep learning radiomics to...
17.
Zhao X, Wu G, Tao X, Dong D, Liu J
Transl Oncol
. 2025 Mar;
54:102340.
PMID: 40048984
Pancreatic cancer (PC) is a highly invasive tumor characterized by delayed diagnosis, rapid progress, and resistance to chemotherapy. Mitochondria, as the "power chamber" of cells, not only play a central...
18.
Salloom R, Sahtout D, Ahmad I, Abdalla M
Transl Oncol
. 2025 Mar;
54:102339.
PMID: 40037158
Prostate cancer (PC) remains a leading cause of morbidity and mortality among men worldwide, highlighting the need for novel therapeutic strategies. Our study investigates the therapeutic potential of targeting the...
19.
Zhao R, Zhang X, Geng Y, Lu D, Wang Y, Xie H, et al.
Transl Oncol
. 2025 Mar;
54:102331.
PMID: 40023001
Introduction: Skin aging is a complex, multifactorial process involving cellular damage, inflammation, and increased susceptibility to diseases. Despite its importance, the role of SPRY1 in skin aging remains poorly understood....
20.
Zhang Y, Xu H, Han X, Yu Q, Xiao H, Zheng L
Transl Oncol
. 2025 Feb;
53:102285.
PMID: 40015830
No abstract available.